Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cord Blood Platelet-rich Plasma (CB-PRP) in Retinitis Pigmentosa and Dry Age-related Macular Degeneration

Authors not listed

Fondazione Policlinico Universitario Agostino Gemelli IRCCS · 2020

Abstract

The study will provides the enrollment of patients with genetic retinal dystrophies with primary rod impairment and dry age-related macular degeneration (Geographic type) A subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP) will be performed only in one eye, the other eye will be considered as a control group. A complete morpho-functional ophthalmological evaluation will be performed in all patients at each control.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2020). Cord Blood Platelet-rich Plasma (CB-PRP) in Retinitis Pigmentosa and Dry Age-related Macular Degeneration. <em>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</em>. https://clinicaltrials.gov/study/NCT04636853
Vancouver
Anonymous. Cord Blood Platelet-rich Plasma (CB-PRP) in Retinitis Pigmentosa and Dry Age-related Macular Degeneration. Fondazione Policlinico Universitario Agostino Gemelli IRCCS. 2020.
BibTeX
@misc{anon2020CordBl, title = {Cord Blood Platelet-rich Plasma (CB-PRP) in Retinitis Pigmentosa and Dry Age-related Macular Degeneration}, author = {Anonymous}, journal = {Fondazione Policlinico Universitario Agostino Gemelli IRCCS}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings